NO20014607D0 - Sammensetninger til forbedring av fertilitet - Google Patents

Sammensetninger til forbedring av fertilitet

Info

Publication number
NO20014607D0
NO20014607D0 NO20014607A NO20014607A NO20014607D0 NO 20014607 D0 NO20014607 D0 NO 20014607D0 NO 20014607 A NO20014607 A NO 20014607A NO 20014607 A NO20014607 A NO 20014607A NO 20014607 D0 NO20014607 D0 NO 20014607D0
Authority
NO
Norway
Prior art keywords
compositions
improving fertility
fertility
improving
Prior art date
Application number
NO20014607A
Other languages
English (en)
Other versions
NO20014607L (no
Inventor
Pierre Broqua
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20014607D0 publication Critical patent/NO20014607D0/no
Publication of NO20014607L publication Critical patent/NO20014607L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20014607A 1999-03-23 2001-09-21 Sammensetninger til forbedring av fertilitet NO20014607L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9906714.2A GB9906714D0 (en) 1999-03-23 1999-03-23 Compositions for improving fertility
PCT/IB2000/000382 WO2000056296A2 (en) 1999-03-23 2000-03-21 Compositions for improving fertility

Publications (2)

Publication Number Publication Date
NO20014607D0 true NO20014607D0 (no) 2001-09-21
NO20014607L NO20014607L (no) 2001-11-20

Family

ID=10850229

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014607A NO20014607L (no) 1999-03-23 2001-09-21 Sammensetninger til forbedring av fertilitet

Country Status (29)

Country Link
US (1) US7115650B1 (no)
EP (1) EP1162969B1 (no)
JP (1) JP2002539243A (no)
KR (1) KR100689951B1 (no)
CN (1) CN1196483C (no)
AR (1) AR023129A1 (no)
AT (1) ATE328594T1 (no)
AU (1) AU765912B2 (no)
CA (1) CA2366911C (no)
CZ (1) CZ20013410A3 (no)
DE (1) DE60028552T2 (no)
DK (1) DK1162969T3 (no)
ES (1) ES2265918T3 (no)
GB (1) GB9906714D0 (no)
HK (1) HK1046647B (no)
HU (1) HUP0200410A3 (no)
IL (1) IL145569A0 (no)
MX (1) MXPA01009612A (no)
MY (1) MY135683A (no)
NO (1) NO20014607L (no)
NZ (1) NZ514449A (no)
PL (1) PL195779B1 (no)
PT (1) PT1162969E (no)
RU (1) RU2246944C2 (no)
TR (1) TR200102647T2 (no)
TW (1) TWI244920B (no)
UA (1) UA77644C2 (no)
WO (1) WO2000056296A2 (no)
ZA (1) ZA200108083B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
GB9928330D0 (en) 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
WO2002072582A1 (en) 2001-03-12 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine template libraries
GB0109146D0 (en) * 2001-04-11 2001-05-30 Ferring Bv Treatment of type 2 diabetes
NZ529973A (en) 2001-06-27 2006-01-27 Smithkline Beecham Corp Fluoropyrrolidines as dipeptidyl peptidase inhibitors
EP1399433B1 (en) 2001-06-27 2007-08-22 Smithkline Beecham Corporation Fluoropyrrolidines as dipeptidyl peptidase inhibitors
JP4300108B2 (ja) 2001-06-27 2009-07-22 スミスクライン ビーチャム コーポレーション ジペプチジルペプチダーゼ阻害剤としてのピロリジン類
DE60304911D1 (de) 2002-02-25 2006-06-08 Eisai Co Ltd Xanthin-Derivate als DPP-IV-Inhibitoren
US6710040B1 (en) 2002-06-04 2004-03-23 Pfizer Inc. Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
EP1514552A4 (en) 2002-06-06 2008-04-02 Eisai R&D Man Co Ltd NEW MILED IMIDAZOLE DERIVATIVE
WO2005026114A1 (en) * 2003-09-17 2005-03-24 Pfizer Inc. Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
SI1942898T2 (sl) 2005-09-14 2014-08-29 Takeda Pharmaceutical Company Limited Dipeptidil-peptidazni inhibitorji za zdravljenje diabetesa
CN102675221A (zh) 2005-09-16 2012-09-19 武田药品工业株式会社 用于制备嘧啶二酮衍生物的方法中的中间体
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
AR077642A1 (es) 2009-07-09 2011-09-14 Arena Pharm Inc Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
EP2556056A1 (en) 2010-04-06 2013-02-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012040279A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140018371A1 (en) 2011-04-01 2014-01-16 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140066369A1 (en) 2011-04-19 2014-03-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
JP2018507914A (ja) 2015-03-09 2018-03-22 インテクリン・セラピューティクス・インコーポレイテッド 非アルコール性脂肪肝疾患および／またはリポジストロフィーの処置のための方法
US11096924B2 (en) * 2016-09-07 2021-08-24 Trustees Of Tufts College Combination therapies using immuno-dash inhibitors and PGE2 antagonists
BR112019020485A2 (pt) 2017-04-03 2020-05-12 Coherus Biosciences, Inc. Agonista ppary para tratamento de paralisia supranuclear progressiva

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2080474A1 (en) 1990-04-14 1991-10-15 William W. Bachovchin Inhibitors of dipeptidyl-aminopeptidase type iv
ATE199016T1 (de) * 1991-10-22 2001-02-15 New England Medical Center Inc Inhibitoren der dipeptidyl-aminopeptidase vom typ-iv
IL111785A0 (en) 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US5952301A (en) 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Also Published As

Publication number Publication date
PL350797A1 (en) 2003-02-10
HUP0200410A3 (en) 2002-09-30
AU765912B2 (en) 2003-10-02
CA2366911A1 (en) 2000-09-28
HK1046647A1 (en) 2003-01-24
PL195779B1 (pl) 2007-10-31
NZ514449A (en) 2002-11-26
DK1162969T3 (da) 2006-09-18
HUP0200410A2 (en) 2002-08-28
DE60028552T2 (de) 2007-06-28
CN1352557A (zh) 2002-06-05
CN1196483C (zh) 2005-04-13
CA2366911C (en) 2010-01-19
US7115650B1 (en) 2006-10-03
ES2265918T3 (es) 2007-03-01
EP1162969B1 (en) 2006-06-07
GB9906714D0 (en) 1999-05-19
KR100689951B1 (ko) 2007-03-08
WO2000056296A3 (en) 2001-01-25
ATE328594T1 (de) 2006-06-15
DE60028552D1 (de) 2006-07-20
RU2246944C2 (ru) 2005-02-27
TR200102647T2 (tr) 2002-01-21
AR023129A1 (es) 2002-09-04
EP1162969A2 (en) 2001-12-19
NO20014607L (no) 2001-11-20
JP2002539243A (ja) 2002-11-19
TWI244920B (en) 2005-12-11
ZA200108083B (en) 2002-11-27
CZ20013410A3 (cs) 2002-04-17
PT1162969E (pt) 2006-10-31
WO2000056296A2 (en) 2000-09-28
UA77644C2 (en) 2007-01-15
MY135683A (en) 2008-06-30
IL145569A0 (en) 2002-06-30
MXPA01009612A (es) 2002-07-02
HK1046647B (zh) 2005-09-30
AU3317700A (en) 2000-10-09
KR20010108388A (ko) 2001-12-07

Similar Documents

Publication Publication Date Title
NO20014607L (no) Sammensetninger til forbedring av fertilitet
AR023440A1 (es) Composiciones antitranspirantes
DE60013221D1 (de) Fotopolymerisierbare Zusammensetzung
DE60000944D1 (de) Bohrlochzementzusammensetzungen
IS6120A (is) Lyfjablanda
DE69919953D1 (de) Funktionelle zusammensetzungen
DE69903404T2 (de) Celecoxib-Zusammensetzungen
EA199900373A3 (ru) Фармацевтические композиции
IT1308627B1 (it) Composizioni fluoroelastomeriche.
DE60040350D1 (de) Weichspülerzusammensetzungen
ID29785A (id) Komposisi-komposisi sampo
DE60033373D1 (de) Flammgeschützte polyolefinzusammensetzungen
DE60007731D1 (de) Schweisshemmende zusammensetzungen
ID22562A (id) Komposisi untuk pembasmi artropoda berbahaya
DE60025624D1 (de) Farbstabile polyarylat enthaltende zusammensetzungen
DE69943245D1 (de) Gaserzeugende zusammensetzung
DE60016836D1 (de) Resistzusammensetzung
PT1158963E (pt) Composicoes de libertacao controlada de beta-histina
ID30272A (id) Komposisi resorsinol
IS5569A (is) Lyfjasamsetningar
ID27329A (id) Komposisi penghambat
DE60005188D1 (de) Grf-haltige lyophilisierte arzneizusammensetzungen
ID30320A (id) Komposisi-komposisi berpigmen
DE60029780D1 (de) Biozide zusammensetzungen
DE60020836D1 (de) Flammhemmende zusammensetzungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application